Dr. Daniel Flynn, MD (he/him) is a Pediatric Endocrinologist in Boise, ID with over 17 years of experience. What is your opinion of Dr. Daniel Flynn, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Daniel Flynn, MD has received over $60,964 which includes payments from the following companies:
$46,401.40 from Novo Nordisk Inc
$7,091.64 from Medtronic MiniMed, Inc.
$1,415.84 from ELI LILLY AND COMPANY
$1,363.53 from Tandem Diabetes Care, Inc.
$1,327.48 from AbbVie, Inc.
$1,325.11 from Endo Pharmaceuticals Inc.
$372.51 from sanofi-aventis U.S. LLC
$316.73 from Abbott Laboratories
$221.73 from Pfizer Inc.
$187.77 from Animas Corporation
$152.64 from Ferring Pharmaceuticals Inc.
$140.87 from Genentech USA, Inc.
$134.78 from LILLY USA, LLC
$119.31 from Horizon Pharma plc
$79.22 from INSULET CORPORATION
$62.72 from Arbor Pharmaceuticals, Inc.
$59.21 from Alexion Pharmaceuticals, Inc.
$42.04 from Dexcom, Inc.
$35.96 from Aegerion Pharmaceuticals, Inc.
$35.42 from Sandoz Inc.
Payments received by Dr. Daniel Flynn, MD were from the following categories:
$34,094.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!